CavaCurmin® (Curcumin Gamma-Cyclodextrin — Wacker)

CavaCurmin® is a high-bioavailability curcumin from Wacker in which turmeric curcuminoids are complexed with gamma-cyclodextrin, a ring-shaped carrier sugar that is shown in a pharmacokinetic study to improve curcumin absorption.

CavaCurmin is researched primarily for Anti-Inflammatory and Joint Health. In a human bioavailability study, the gamma-cyclodextrin curcumin complex delivered substantially higher blood levels of curcuminoids than standard curcumin, addressing curcumin's biggest weakness.

The clinically studied dose is About 500 mg of the complex per day; the bioavailability study compared standardized doses across formulations. Always follow the product label and check with a healthcare provider for personal advice.

For most healthy adults, CavaCurmin is well tolerated at studied doses. Reported effects can include: Generally well-tolerated — curcumin is well tolerated even at higher absorbed levels. Mild digestive upset is occasionally reported. It may also interact with some medications. CavaCurmin is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Possible interactions include: Anticoagulants and antiplatelets — curcumin may add to bleeding risk; monitor. Diabetes medication — curcumin may lower blood sugar; watch levels. If you take prescription medication, check with a pharmacist or doctor before using it.

NutraSmarts rates the evidence for CavaCurmin as Limited (2 out of 5). It is backed by 1 clinical trial and 1 cited reference summarized on this page. A higher rating reflects more, larger, and better-designed human studies.